Status:
COMPLETED
Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
Lead Sponsor:
AstraZeneca
Conditions:
Ulcers
Upper GI Symptoms
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to test if fixed dose esomeprazole and ASA capsule is pharmaceutically equal to a free combination of esomeprazole capsule and ASA tablet
Eligibility Criteria
Inclusion
- Body mass index of 19-29kg/m2, inclusive
- Weight of 50-95kg, inclusive
- Clinically normal physical findings and laboratory values including hepatitis B, hepatitis C, and HIV, as judged by the Investigator
Exclusion
- Significant clinical illness within the 2 weeks preceding the first dose of investigational products, as judged by the Investigator
- History of mental, cardiac, renal, hepatitis, neurological, or significant gastrointestinal disease, as judged by the Investigator
- Condition which could modify the absorption of the investigational products, as judged by the Investigator
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2008
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00688428
Start Date
April 1 2008
End Date
April 1 2008
Last Update
March 12 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.